Trial Details

COMPLETED
Basic Information
Clinical ID c3905
Identifier NCT01346826
Trial Title Safety of Accelerated Infliximab Infusions in Patients With Inflammatory Bowel Disease (IBD)
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Crohn's Disease|Ulcerative Colitis
Interventions DRUG: Standard 2 hours-infusion|DRUG: Accelerated 1 hour-infusion|DRUG: Accelerated 30 minutes-infusion
Participant Information
Sponsor Asan Medical Center
City Seoul
Country/Region South Korea
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD, ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE4
Time Information
Start Date 2011-05
Primary Completion Date 2015-10
Completion Date 2016-04